BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CDX2, CDX3, 1045, ENSG00000165556, Q99626
72 results:

  • 1. Patterns of follow-up care in adult blood cancer survivors-Prospective evaluation of health-related outcomes, resource use, and quality of life.
    Lax H; Baum J; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
    Cancer Med; 2024 Apr; 13(7):e7095. PubMed ID: 38549460
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clusters, crop dusters, and myth busters: a scoping review of environmental exposures and cutaneous T-cell lymphoma.
    Gordon ER; Adeuyan O; Schreidah CM; Chen C; Trager MH; Lapolla BA; Fahmy LM; Weng C; Geskin LJ
    Ital J Dermatol Venerol; 2023 Dec; 158(6):467-482. PubMed ID: 38015484
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma.
    Lin Z; Ma J; Ma Y; Li Q; Kang H; Zhang M; Chen B; Xia R
    Front Immunol; 2023; 14():1191033. PubMed ID: 37426647
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patient-reported patterns of follow-up care in the 'Aftercare in Blood Cancer Survivors' (ABC) study.
    Baum J; Lax H; Lehmann N; Merkel-Jens A; Beelen DW; Jöckel KH; Dührsen U
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10531-10542. PubMed ID: 37291404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
    Clavero E; Sanchez-Maldonado JM; Macauda A; Ter Horst R; Sampaio-Marques B; Jurczyszyn A; Clay-Gilmour A; Stein A; Hildebrandt MAT; Weinhold N; Buda G; García-Sanz R; Tomczak W; Vogel U; Jerez A; Zawirska D; Wątek M; Hofmann JN; Landi S; Spinelli JJ; Butrym A; Kumar A; Martínez-López J; Galimberti S; Sarasquete ME; Subocz E; Iskierka-Jażdżewska E; Giles GG; Rybicka-Ramos M; Kruszewski M; Abildgaard N; Verdejo FG; Sánchez Rovira P; da Silva Filho MI; Kadar K; Razny M; Cozen W; Pelosini M; Jurado M; Bhatti P; Dudzinski M; Druzd-Sitek A; Orciuolo E; Li Y; Norman AD; Zaucha JM; Reis RM; Markiewicz M; Rodríguez Sevilla JJ; Andersen V; Jamroziak K; Hemminki K; Berndt SI; Rajkumar V; Mazur G; Kumar SK; Ludovico P; Nagler A; Chanock SJ; Dumontet C; Machiela MJ; Varkonyi J; Camp NJ; Ziv E; Vangsted AJ; Brown EE; Campa D; Vachon CM; Netea MG; Canzian F; Försti A; Sainz J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239846
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.
    Zhao X; Qian M; Goodings C; Zhang Y; Yang W; Wang P; Xu B; Tian C; Pui CH; Hunger SP; Raetz EA; Devidas M; Relling MV; Loh ML; Savic D; Li C; Yang JJ
    J Natl Cancer Inst; 2022 Sep; 114(9):1287-1295. PubMed ID: 35575404
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Concurrent cdx2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
    Passet M; Kim R; Gachet S; Sigaux F; Chaumeil J; Galland A; Sexton T; Quentin S; Hernandez L; Larcher L; Bergugnat H; Ye T; Karasu N; Caye A; Heizmann B; Duluc I; Chevallier P; Rousselot P; Huguet F; Leguay T; Hunault M; Pflumio F; Freund JN; Lobry C; Lhéritier V; Dombret H; Domon-Dell C; Soulier J; Boissel N; Clappier E
    Blood; 2022 Jun; 139(24):3505-3518. PubMed ID: 35316324
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Enhancer retargeting of cdx2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
    Kimura S; Montefiori L; Iacobucci I; Zhao Y; Gao Q; Paietta EM; Haferlach C; Laird AD; Mead PE; Gu Z; Stock W; Litzow M; Rowe JM; Luger SM; Hunger SP; Ryland GL; Schmidt B; Ekert PG; Oshlack A; Grimmond SM; Rehn J; Breen J; Yeung D; White DL; Aldoss I; Jabbour EJ; Pui CH; Meggendorfer M; Walter W; Kern W; Haferlach T; Brady S; Zhang J; Roberts KG; Blombery P; Mullighan CG
    Blood; 2022 Jun; 139(24):3519-3531. PubMed ID: 35192684
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection.
    Chen XM; Sun L; Yang K; Chen JM; Zhang L; Han XY; Zhou X; Ma ZY; Li M; Zhao HX; Qi LM; Wang P
    BMC Pulm Med; 2022 Feb; 22(1):55. PubMed ID: 35130846
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
    Shukla S; Pandey RK; Husain N; Srivastava A
    Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of cdx2 and IDH1/2 mutations.
    Yasuda T; Sanada M; Kawazu M; Kojima S; Tsuzuki S; Ueno H; Iwamoto E; Iijima-Yamashita Y; Yamada T; Kanamori T; Nishimura R; Kuwatsuka Y; Takada S; Tanaka M; Ota S; Dobashi N; Yamazaki E; Hirose A; Murayama T; Sumi M; Sato S; Tange N; Nakamura Y; Katsuoka Y; Sakaida E; Kawamata T; Iida H; Shiraishi Y; Nannya Y; Ogawa S; Taniwaki M; Asou N; Hatta Y; Kiyoi H; Matsumura I; Horibe K; Mano H; Naoe T; Miyazaki Y; Hayakawa F
    Blood; 2022 Mar; 139(12):1850-1862. PubMed ID: 34695176
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries.
    Kilgore KM; Mohammadi I; Wong AC; Snider JT; Cheng P; Schroeder A; Patel AR
    Future Oncol; 2021 Dec; 17(35):4837-4847. PubMed ID: 34645318
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Familial patterns of hematologic precursors.
    Landgren O; Maura F
    Blood; 2021 Apr; 137(15):1992-1993. PubMed ID: 33856447
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
    Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
    Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin's lymphoma: a case-control study.
    Mashhadi MA; Arbabi N; Sepehri Rad N; Sargazi S; Harati-Sadegh M
    Nucleosides Nucleotides Nucleic Acids; 2021; 40(3):288-299. PubMed ID: 33446057
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Expression of Hsa-miR-9 in Children with Acute Lymphoblastic Leukemia and Its Relationship with cdx2 Gene].
    Wang RC; Yang J; Zhang XX; Gao XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1523-1527. PubMed ID: 33067948
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Vitamin D Receptor Polymorphisms and Cancer.
    Gnagnarella P; Raimondi S; Aristarco V; Johansson HA; Bellerba F; Corso F; Gandini S
    Adv Exp Med Biol; 2020; 1268():53-114. PubMed ID: 32918214
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
    Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
    Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell lymphoma in China.
    Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
    Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.